Specialty Pharmaceuticals Company Equity Stake For Sale in Corona, USA
Pre-revenue migraine drug under development seeking investment to progress clinical trials and regulatory approvals.
| Established | 10-20 year(s) |
| Employees | 2 - 5 |
| Legal Entity | Limited Liability Company (LLC) |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Specialty Pharmaceuticals |
| Locations | Corona |
| Local Time | 5:16 PM America / Chicago |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
100 thousand
for
20.0%
stake
(Native Currency: USD 100,000)
Reason: Seeking funds for completing Phase I/II, recruitment, regulatory management, and trial drug manufact...
View More
Includes physical assets worth
USD
10 thousand
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Business Overview
- Developing a novel pharmaceutical drug targeting the treatment of chronic and episodic migraine conditions.
- Designed to address neurological conditions, including trigeminal neuralgia, through specialized therapeutic intervention.
- Intended for use in clinical settings under supervision of medical professionals.
- Currently in pre-revenue stage with no commercial sales, as the product is awaiting clinical trial progression.
- Registered under the FDA IND pathway, indicating initial regulatory alignment for clinical development.
- Further regulatory approvals, such as successful completion of clinical trials and drug approval, will be required before commercialization.
- Positioned as an early-stage drug development opportunity within the neurology and pain management segment.
- Focused on addressing unmet medical needs in migraine and related neurological disorders.
- Designed to address neurological conditions, including trigeminal neuralgia, through specialized therapeutic intervention.
- Intended for use in clinical settings under supervision of medical professionals.
- Currently in pre-revenue stage with no commercial sales, as the product is awaiting clinical trial progression.
- Registered under the FDA IND pathway, indicating initial regulatory alignment for clinical development.
- Further regulatory approvals, such as successful completion of clinical trials and drug approval, will be required before commercialization.
- Positioned as an early-stage drug development opportunity within the neurology and pain management segment.
- Focused on addressing unmet medical needs in migraine and related neurological disorders.
Products & Services Overview
Core offering is a novel drug under development for migraine and neurological conditions, intended for use by healthcare providers and clinical institutions.
Assets Overview
Laboratory and research materials, documents, communications, row material.
Facilities Overview
The business is currently operating from a rented lab in Corona, Riverside County.
Capitalization Overview
Owned by a sole owner.No debts.
Tags:
Specialty Pharmaceuticals Company Investment Opportunity in Corona, USA
·Specialty Pharmaceuticals Company Equity Stake For Sale in Corona, USA
·Invest in Specialty Pharmaceuticals Company in Corona, USA
·Specialty Pharmaceuticals Company Investment Opportunity
·Invest in Specialty Pharmaceuticals Company
·Investment Opportunity in Corona, USA
·Invest in Corona, USA
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
1 Investor viewed this Business this week.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 66,500+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses